Rank | Holder | SharesFloat % | Change | Date reported |
---|---|---|---|---|
1 | Baillie Gifford & Co Limited. | 8.16M (8.39%) | -60.90K Decreased by -0.75% | Mar 31, 25 |
2 | FMR Inc | 7.28M (7.49%) | -418.06K Decreased by -5.74% | Mar 31, 25 |
3 | Flossbach von Storch AG | 4.26M (4.38%) | -147.21K Decreased by -3.46% | Mar 31, 25 |
4 | PRIMECAP Management Company | 4.05M (4.16%) | -249.39K Decreased by -6.16% | Mar 31, 25 |
5 | Pfizer Inc | 3.66M (3.76%) | 0.00 Increased by 0.00% | Mar 31, 25 |
6 | Harding Loevner L.P. | 2.93M (3.01%) | -891.40K Decreased by -30.46% | Jun 30, 24 |
7 | Temasek Holdings Ltd. | 1.81M (1.86%) | 0.00 Increased by 0.00% | Mar 31, 25 |
8 | BlackRock Inc | 1.67M (1.71%) | -190.47K Decreased by -11.43% | Mar 31, 25 |
9 | Capital Research & Mgmt Co - Division 3 | 1.43M (1.47%) | 12.88K Increased by +0.90% | Mar 31, 25 |
10 | BNP Paribas Arbitrage, SA | 1.20M (1.23%) | 581.17K Increased by +48.61% | Mar 31, 25 |
11 | UBS Asset Mgmt Americas Inc | 995.25K (1.02%) | 137.12K Increased by +13.78% | Dec 31, 23 |
12 | Capital World Investors | 955.98K (0.98%) | 12.86K Increased by +1.35% | Jun 30, 24 |
13 | Viking Global Investors LP | 879.97K (0.90%) | -60.88K Decreased by -6.92% | Mar 31, 25 |
14 | Artisan Partners Limited Partnership | 734.62K (0.76%) | -1.30M Decreased by -176.37% | Sep 30, 23 |
15 | Morgan Stanley - Brokerage Accounts | 713.61K (0.73%) | -29.78K Decreased by -4.17% | Mar 31, 25 |
16 | Bank of New York Mellon Corp | 698.37K (0.72%) | 694.69K Increased by +99.47% | Mar 31, 25 |
17 | Candriam Luxembourg S.C.A. | 670.96K (0.69%) | -175.98K Decreased by -26.23% | Mar 31, 25 |
18 | Gilder Gagnon Howe & CO LLC | 649.28K (0.67%) | 367.87K Increased by +56.66% | Mar 31, 25 |
19 | Amvescap Plc. | 645.14K (0.66%) | 558.39K Increased by +86.55% | Mar 31, 25 |
20 | Capital International Inc /ca/ | 638.10K (0.66%) | -30.22K Decreased by -4.74% | Mar 31, 25 |
Rank | Holder | SharesFloat % | Change | Date reported |
---|---|---|---|---|
1 | Performer (AFRIS) | 30.26M (31.11%) | 30.26M Increased by +100.00% | Feb 29, 24 |
2 | Franklin All Country World ex US Equity | 20.00M (20.56%) | 20.00M Increased by +100.00% | Mar 31, 25 |
3 | FvS SICAV Multiple Opportunities F | 2.73M (2.80%) | 0.00 Increased by 0.00% | Feb 28, 25 |
4 | AF High Growth (AFRIS) | 2.30M (2.36%) | 2.30M Increased by +100.00% | Feb 29, 24 |
5 | Vanguard Capital Opportunity Inv | 2.16M (2.22%) | -108.62K Decreased by -5.02% | Mar 31, 25 |
6 | Harding Loevner International Eq Instl | 1.29M (1.33%) | -561.45K Decreased by -43.40% | Jun 30, 24 |
7 | FvS Multiple Opportunities II I | 1.26M (1.30%) | 0.00 Increased by 0.00% | Feb 28, 25 |
8 | Global Balanced (AFRIS) | 1.05M (1.08%) | 1.05M Increased by +100.00% | Feb 29, 24 |
9 | PRIMECAP Odyssey Aggressive Growth | 1.04M (1.07%) | -92.91K Decreased by -8.90% | Mar 31, 25 |
10 | iShares Biotechnology ETF | 965.27K (0.99%) | 0.00 Increased by 0.00% | May 31, 25 |
11 | Strategic Advisers Fidelity US TtlStk | 897.30K (0.92%) | 66.00K Increased by +7.36% | Apr 30, 25 |
12 | American Funds New Perspective A | 798.14K (0.82%) | -1.38K Decreased by -0.17% | Jun 30, 24 |
13 | Capital Group New Perspective Comp | 798.14K (0.82%) | -1.38K Decreased by -0.17% | Jun 30, 24 |
14 | American Funds EUPAC A | 741.31K (0.76%) | 0.00 Increased by 0.00% | Mar 31, 25 |
15 | American Funds Europacific Growth A | 741.31K (0.76%) | 0.00 Increased by 0.00% | Mar 31, 25 |
16 | Capital Group EUPAC Composite | 741.31K (0.76%) | 0.00 Increased by 0.00% | Mar 31, 25 |
17 | Capital Group EuroPacific Growth Comp | 741.31K (0.76%) | 0.00 Increased by 0.00% | Mar 31, 25 |
18 | Fidelity Series Value Discovery | 720.20K (0.74%) | 0.00 Increased by 0.00% | Apr 30, 25 |
19 | Invesco Developing Markets A | 652.56K (0.67%) | 150.64K Increased by +23.08% | Apr 30, 25 |
20 | Baillie Gifford WW L/T Glb Gr B USD Acc | 632.37K (0.65%) | -5.09K Decreased by -0.80% | Apr 30, 25 |